Abstract
Muscle-invasive bladder cancer is a deadly condition in dire need of effective new treatments. This unit contains a description of mouse models suitable for the evaluation of potential new therapies. Included is a genetically engineered mouse model of bladder cancer generated by the delivery of an adenovirus expressing Cre recombinase into the bladder lumen. Also described is an orthotopic mouse model created by the instillation of human bladder tumor cells into the bladder lumen of immune deficient mice. Protocols are also provided on the use of these models for the preclinical evaluation of new chemical entities, with mTOR inhibitors shown as an example.
Original language | English (US) |
---|---|
Pages (from-to) | 14.14.1-14.14.18 |
Journal | Current Protocols in Pharmacology |
Issue number | SUPPL. 49 |
DOIs | |
State | Published - Jun 2010 |
Funding
Keywords
- GEM mouse models
- bladder cancer
- mTOR inhibition
- orthotopic models
- preclinical studies
ASJC Scopus subject areas
- Pharmacology